Profile data is unavailable for this security.
About the company
Zhejiang Medicine Co., Ltd. is a China-based company, principally engaged in the manufacture and distribution of drugs and nourishments. The Company mainly provides nourishments for animals and human, health care products, and chemicals and chemical raw materials, among others. The Company's products include synthetic vitamin E, natural vitamin E soft capsules, Beta carotene, vancomycin hydrochloride for injection and teicoplanin for injection, among others. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)8.26bn
- Net income in CNY472.71m
- Incorporated1997
- Employees6.23k
- LocationZhejiang Medicine Co LtdNo. 168 Zhiyuanzhong AvenueBinhai XinchengSHAOXING 312366ChinaCHN
- Phone+86 57 585211969
- Fax+86 57 585211976
- Websitehttps://www.zmc.top/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.46bn | 348.25m | 13.55bn | 1.55k | 39.55 | 5.53 | -- | 9.25 | 1.56 | 1.56 | 6.68 | 11.14 | 0.4415 | 1.33 | 4.30 | 947,744.50 | 10.78 | 5.86 | 15.22 | 7.59 | 64.95 | 55.41 | 24.41 | 17.20 | 1.03 | 35.28 | 0.3352 | 27.59 | 58.69 | 32.24 | 26.20 | 29.99 | 27.32 | -- |
| Jiang Zhong Pharmaceutical Co Ltd | 4.27bn | 750.04m | 14.06bn | 4.01k | 18.65 | 3.62 | -- | 3.30 | 1.20 | 1.20 | 6.81 | 6.18 | 0.6927 | 3.93 | 14.22 | 1,062,816.00 | 13.27 | 10.82 | 20.40 | 15.08 | 64.28 | 65.02 | 19.15 | 18.17 | 1.16 | -- | 0.0108 | 82.88 | 13.00 | 20.12 | 18.40 | 8.54 | 11.47 | 40.99 |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.13bn | 329.37m | 14.17bn | 965.00 | 43.03 | 2.84 | -- | 12.51 | 0.534 | 0.534 | 1.84 | 8.09 | 0.2171 | 1.47 | 6.75 | 1,173,933.00 | 6.11 | 1.32 | 6.42 | 1.41 | 75.86 | 80.74 | 28.12 | 6.55 | 6.30 | -- | 0.01 | 8.25 | 22.84 | -2.35 | 497.63 | -4.44 | 21.22 | -- |
| Chongqing Taiji Industry Group Co Ltd | 14.39bn | 751.39m | 14.36bn | 12.59k | 19.11 | 3.63 | -- | 0.9978 | 1.35 | 1.35 | 25.84 | 7.09 | 0.9796 | 2.87 | 5.20 | 1,142,939.00 | 5.34 | 0.7814 | 15.69 | 2.35 | 45.37 | 44.03 | 5.45 | 0.8498 | 0.4824 | 5.48 | 0.5278 | 25.76 | 10.58 | 7.88 | 131.99 | 63.55 | 3.86 | 24.57 |
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.52bn | 664.16m | 14.40bn | 2.53k | 21.65 | 5.29 | -- | 4.10 | 1.17 | 1.17 | 6.22 | 4.80 | 0.7764 | 2.17 | 12.17 | 1,390,046.00 | 14.66 | 10.68 | 24.66 | 16.56 | 72.45 | 74.42 | 18.89 | 14.92 | 0.8563 | -- | 0.037 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
| BrightGene Bio-Medical Technology Co Ltd | 1.25bn | 199.39m | 14.63bn | 1.16k | 74.56 | 6.12 | -- | 11.71 | 0.4645 | 0.4645 | 2.95 | 5.66 | 0.2488 | 1.71 | 4.04 | 1,082,012.00 | 3.13 | 6.53 | 3.87 | 7.93 | 54.94 | 56.93 | 12.58 | 19.90 | 1.39 | 4.78 | 0.4994 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.03bn | 886.52m | 14.81bn | 4.88k | 16.57 | 1.76 | -- | 2.94 | 0.994 | 0.994 | 5.63 | 9.33 | 0.4482 | 1.81 | 4.31 | 1,031,998.00 | 7.89 | 10.10 | 10.04 | 13.69 | 34.64 | 34.64 | 17.60 | 16.26 | 2.36 | -- | 0.0765 | 40.79 | 1.44 | 24.29 | 12.20 | 45.74 | 32.14 | 20.11 |
| Zhejiang Medicine Co., Ltd. | 8.26bn | 472.71m | 15.31bn | 6.23k | 31.73 | 1.54 | -- | 1.85 | 0.5017 | 0.5017 | 8.72 | 10.34 | 0.6455 | 2.81 | 6.18 | 1,326,750.00 | 2.70 | 4.32 | 3.41 | 5.68 | 32.28 | 36.57 | 4.18 | 6.28 | 1.77 | 3.64 | 0.0755 | 58.72 | -3.96 | 2.59 | -20.37 | 3.34 | 12.65 | 0.00 |
| Tonghua Dongbao Pharmaceutical Co Ltd | 2.45bn | 452.54m | 16.29bn | 3.20k | 39.13 | 2.51 | -- | 6.65 | 0.2101 | 0.2101 | 1.25 | 3.28 | 0.3527 | 0.697 | 4.25 | 766,304.10 | 6.51 | 18.68 | 6.85 | 19.68 | 78.80 | 78.73 | 18.47 | 39.20 | 3.07 | -- | 0.0524 | 41.73 | 10.69 | 2.69 | -26.17 | 6.85 | -14.75 | 4.56 |
| Shanghai Shyndec Pharmaceutical Co Ltd | 11.59bn | 1.07bn | 16.58bn | 11.61k | 15.56 | 1.28 | -- | 1.43 | 0.7945 | 0.7945 | 8.64 | 9.67 | 0.5953 | 3.17 | 6.50 | 998,061.50 | 6.87 | 4.85 | 10.06 | 8.17 | 37.32 | 43.00 | 11.54 | 7.03 | 1.97 | -- | 0.104 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
Data as of Oct 11 2024. Currency figures normalised to Zhejiang Medicine Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 18.25m | 1.91% |
| Shanghai Wealspring Asset Management Co. Ltd.as of 30 Jun 2023 | 4.77m | 0.50% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 3.88m | 0.41% |
| Galaxy Asset Management Co., Ltd.as of 31 Dec 2023 | 3.16m | 0.33% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 2.33m | 0.24% |
| Wanjia Asset Management Co., Ltd.as of 31 Dec 2023 | 1.87m | 0.20% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 1.62m | 0.17% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 1.57m | 0.16% |
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 1.57m | 0.16% |
| Mackenzie Financial Corp.as of 31 Mar 2024 | 1.48m | 0.16% |
More ▼
Data from 31 Dec 2023 - 25 Jul 2024Source: FactSet Research Systems Inc.
